These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26540380)

  • 1. Delivering the goods: scientists seek a way to make CRISPR-Cas gene editing more targeted.
    Keener AB
    Nat Med; 2015 Nov; 21(11):1239-41. PubMed ID: 26540380
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientists Correct a Pathogenic Gene Mutation in Human Embryos.
    Hampton T
    Circulation; 2017 Oct; 136(15):1449-1450. PubMed ID: 28993374
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome editing: the end of the beginning.
    Doudna JA; Gersbach CA
    Genome Biol; 2015 Dec; 16():292. PubMed ID: 26700220
    [No Abstract]   [Full Text] [Related]  

  • 4. At the Heart of Genome Editing and Cardiovascular Diseases.
    Hernandez-Benitez R; Martinez-Martinez ML; Lajara J; Magistretti P; Montserrat N; Izpisua Belmonte JC
    Circ Res; 2018 Jul; 123(2):221-223. PubMed ID: 29976689
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial scissors to edit human embryos?
    Gross M
    Curr Biol; 2015 Jun; 25(11):R439-42. PubMed ID: 26230009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini enzyme moves gene editing closer to the clinic.
    Ledford H
    Nature; 2015 Apr; 520(7545):18. PubMed ID: 25832387
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral Vectors, Engineered Cells and the CRISPR Revolution.
    DiCarlo JE; Deeconda A; Tsang SH
    Adv Exp Med Biol; 2017; 1016():3-27. PubMed ID: 29130151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
    Ul Ain Q; Chung JY; Kim YH
    J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
    Bak RO; Porteus MH
    Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
    Kuruvilla J; Sasmita AO; Ling APK
    Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD.
    Wang JZ; Wu P; Shi ZM; Xu YL; Liu ZJ
    Brain Dev; 2017 Aug; 39(7):547-556. PubMed ID: 28390761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors.
    Li L; He ZY; Wei XW; Gao GP; Wei YQ
    Hum Gene Ther; 2015 Jul; 26(7):452-62. PubMed ID: 26176432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Emeritus Dinosaur's viewpoint - The road to hell of gene therapists is paved with POC].
    Kaplan JC
    Med Sci (Paris); 2015 Nov; 31 Spec No 3():41-4. PubMed ID: 26546933
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.